Primary Outcome
−2.7
The IHTG content was reduced by 8.3% (95% CI, −10.0% to −6.6%) at 6 months and 6.9% (95% CI, −8.8% to −5.1%) at 12 months in the TRE group. Likewise, it was reduced by 8.1% (95% CI, −9.8% to −6.4%) at the 6-month assessment and 7.9% (95% CI, −9.7% to −6.2%) at 12 months in the DCR group. However, the net change in IHTG content was not significantly different between the groups at the 6-month (percentage point difference: −0.2; 95% CI, −2.7 to 2.2; 